Monotherapy for partial epilepsy: focus on levetiracetam
about
Insights from zebrafish and mouse models on the activity and safety of ar-turmerone as a potential drug candidate for the treatment of epilepsyExploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesisEvidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disordersBrivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy.
P2860
Monotherapy for partial epilepsy: focus on levetiracetam
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Monotherapy for partial epilepsy: focus on levetiracetam
@ast
Monotherapy for partial epilepsy: focus on levetiracetam
@en
Monotherapy for partial epilepsy: focus on levetiracetam
@nl
type
label
Monotherapy for partial epilepsy: focus on levetiracetam
@ast
Monotherapy for partial epilepsy: focus on levetiracetam
@en
Monotherapy for partial epilepsy: focus on levetiracetam
@nl
prefLabel
Monotherapy for partial epilepsy: focus on levetiracetam
@ast
Monotherapy for partial epilepsy: focus on levetiracetam
@en
Monotherapy for partial epilepsy: focus on levetiracetam
@nl
P2093
P2860
P356
P1476
Monotherapy for partial epilepsy: focus on levetiracetam
@en
P2093
Angelo Labate
Eleonora Colosimo
Roberta Ambrosio
P2860
P356
10.2147/NDT.S1655
P407
P577
2008-02-01T00:00:00Z